Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.300
+0.040 (3.17%)
Jul 31, 2026, 4:08 PM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 2.7 billion as of July 31, 2026. Its market cap has decreased by -26.91% in one year.
Market Cap
2.70B
Enterprise Value
2.98B
Revenue
1.92B
Ranking
n/a
PE Ratio
12.98
Stock Price
1.30
ChartMarket Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 2.70B, a decrease of -59.32%. That is a compound annual growth rate of -11.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.70B | -28.99% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.24B |
| HJ Science | 3.13B |
| Jiangsu Recbio Technology | 3.11B |
| Shandong Boan Biotechnology | 3.02B |
| Beijing Luzhu Biotechnology | 2.79B |
| TYK Medicines | 2.76B |
| Antengene Corporation | 2.72B |
| BioDlink International Company | 2.51B |